Ketoanalogues Supplementation Decreases Dialysis and Mortality Risk in Patients With Anemic Advanced Chronic Kidney Disease

PLoS ONE - United States
doi 10.1371/journal.pone.0176847
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients With Advanced Chronic Kidney Disease

PLoS ONE
Multidisciplinary
2017English

Hyperphosphatemia in Chronic Kidney Disease: Patient Characteristics and Dialysis Mortality During the First Year of Dialysis

Journal of Nephrology & Therapeutics
2012English

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Chronic Kidney Disease and Mortality Risk: A Systematic Review

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

The Relationship Between Medication Discrepancies and Hospitalization Risk Among Patients With Advanced Chronic Kidney Disease

Kidney International Reports
Nephrology
2020English

Optimal Start in Dialysis Shows Increased Survival in Patients With Chronic Kidney Disease

PLoS ONE
Multidisciplinary
2019English

Rebuttal: CON Position. Should Hemoglobin Targets for Anemic Patients With Chronic Kidney Disease Be Changed

American Journal of Nephrology
Nephrology
2010English

Oral Manifestation and Caries Experience in Pre-Dialysis Chronic Kidney Disease Patients

Archives of Orofacial Sciences
Oral SurgeryOrthodontics
2019English

Study on Correlation Between eGFR and Atherosclerosis in Patients With Non-Dialysis Chronic Kidney Disease

Heart
Cardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy